US EditionPublished • loading... • Updated
House PBM reforms head to Senate with widespread pharmacy backing
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
House PBM reforms head to Senate with widespread pharmacy backing
WASHINGTON — Momentum is growing for the most comprehensive federal action on pharmacy benefit manager reform to date after the U.S. House of Representatives approved the Consolidated Appropriations Act of 2026, a must-pass funding package that includes significant changes to PBM practices across Medicare and the commercial market. The bill now moves to the Senate ahead of a Jan. 30 government-funding deadline, with pharmacy organizations urging…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
